PI and Director
Katherine Luzuriaga, M.D.
As a physician-scientist, Dr. Luzuriaga uses scientific investigation to improve human health. Her research has provided key insights into understanding viral and host factors that result in persistent viral (human immunodeficiency virus, Epstein Barr virus, and cytomegalovirus) infections in children. She has also been active in translational research that defined the timing of mother-to-child HIV transmission, led to the pediatric labeling of multiple antiretrovirals (including nevirapine), and conducted the first early therapy trials in HIV-infected infants. She was also part of a team that developed a SARS monoclonal antibody for clinical use.
As Director and PI of the University of Massachusetts Center for Clinical and Translational Science (UMCCTS), Dr. Luzuriaga leads transdisciplinary efforts across the five UMass campuses (Amherst, Boston, Dartmouth, Lowell, and Worcester) to translate basic science discoveries into products/approaches that improve human health and to train the next generation of translational scientists.
Dr. Luzuriaga completed undergraduate and master’s degrees in Biochemistry at the Massachusetts Institute of Technology (MIT) and her medical degree at Tufts University School of Medicine. After serving a residency in pediatrics at the Floating Hospital for Children, Tufts Medical Center, Dr. Luzuriaga completed clinical and research fellowship training in adult and pediatric infectious diseases at the University of Massachusetts Medical School.